Kentucky Retirement Systems decreased its holdings in Albemarle Co. (NYSE:ALB – Free Report) by 5.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,912 shares of the specialty chemicals company’s stock after selling 477 shares during the period. Kentucky Retirement Systems’ holdings in Albemarle were worth $1,174,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of Albemarle by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 14,083,522 shares of the specialty chemicals company’s stock worth $2,034,787,000 after acquiring an additional 82,874 shares during the period. Capital Research Global Investors boosted its stake in Albemarle by 128.5% during the fourth quarter. Capital Research Global Investors now owns 7,076,357 shares of the specialty chemicals company’s stock valued at $1,022,420,000 after buying an additional 3,979,885 shares during the last quarter. Capital International Investors boosted its stake in Albemarle by 31.7% during the fourth quarter. Capital International Investors now owns 5,800,219 shares of the specialty chemicals company’s stock valued at $838,025,000 after buying an additional 1,396,624 shares during the last quarter. Franklin Resources Inc. boosted its stake in Albemarle by 47.4% during the fourth quarter. Franklin Resources Inc. now owns 5,185,734 shares of the specialty chemicals company’s stock valued at $749,235,000 after buying an additional 1,667,164 shares during the last quarter. Finally, Primecap Management Co. CA boosted its stake in Albemarle by 55.8% during the fourth quarter. Primecap Management Co. CA now owns 3,476,674 shares of the specialty chemicals company’s stock valued at $502,310,000 after buying an additional 1,245,719 shares during the last quarter. Institutional investors own 92.87% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on ALB. Scotiabank reiterated a “sector perform” rating and issued a $135.00 price target (down from $150.00) on shares of Albemarle in a report on Tuesday, May 21st. Deutsche Bank Aktiengesellschaft raised their price objective on Albemarle from $125.00 to $140.00 and gave the stock a “hold” rating in a report on Tuesday, May 7th. Citigroup reduced their price objective on Albemarle from $137.00 to $100.00 and set a “neutral” rating on the stock in a report on Friday, July 12th. Wells Fargo & Company downgraded Albemarle from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $145.00 to $100.00 in a report on Thursday, July 11th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $157.00 price objective on shares of Albemarle in a report on Friday, May 24th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $145.65.
Insider Transactions at Albemarle
In related news, CAO John Clarence Barichivich III sold 1,475 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $132.17, for a total value of $194,950.75. Following the transaction, the chief accounting officer now owns 4,743 shares in the company, valued at approximately $626,882.31. The sale was disclosed in a filing with the SEC, which is available through this link. In other Albemarle news, CAO John Clarence Barichivich III sold 1,475 shares of the stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $132.17, for a total transaction of $194,950.75. Following the sale, the chief accounting officer now directly owns 4,743 shares of the company’s stock, valued at approximately $626,882.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Richard Mummert sold 843 shares of the business’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $135.53, for a total value of $114,251.79. Following the completion of the transaction, the senior vice president now directly owns 6,802 shares of the company’s stock, valued at approximately $921,875.06. The disclosure for this sale can be found here. Company insiders own 0.38% of the company’s stock.
Albemarle Stock Performance
Shares of Albemarle stock traded down $1.37 during midday trading on Monday, hitting $91.43. The company had a trading volume of 834,170 shares, compared to its average volume of 3,020,787. The company has a fifty day simple moving average of $105.63 and a 200 day simple moving average of $116.60. The stock has a market cap of $10.75 billion, a price-to-earnings ratio of 33.12, a PEG ratio of 3.47 and a beta of 1.57. The company has a quick ratio of 1.91, a current ratio of 2.84 and a debt-to-equity ratio of 0.37. Albemarle Co. has a 12-month low of $90.02 and a 12-month high of $215.82.
Albemarle (NYSE:ALB – Get Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The specialty chemicals company reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.09). The company had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Albemarle had a return on equity of 14.53% and a net margin of 4.02%. The company’s quarterly revenue was down 47.3% on a year-over-year basis. During the same period in the prior year, the business posted $10.32 EPS. As a group, analysts predict that Albemarle Co. will post 1.67 earnings per share for the current fiscal year.
Albemarle Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 1st. Shareholders of record on Friday, September 13th will be paid a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend is Friday, September 13th. This is an increase from Albemarle’s previous quarterly dividend of $0.40. Albemarle’s payout ratio is presently 58.18%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Read More
- Five stocks we like better than Albemarle
- Most Volatile Stocks, What Investors Need to Know
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- Are Penny Stocks a Good Fit for Your Portfolio?
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.